Offer - Urjas Oil for just ₹ 1
Fivasa is a commercial drug that is prescribed in the form of Capsule, Cream, Spray. Allergic Rhinitis are some of its major therapeutic uses. Secondary and off-label uses of Fivasa have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Fivasa. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Fivasa are Throat Irritation, Nausea or vomiting, Nosebleed. Apart from the aforementioned side effects, Fivasa can also lead to other problems, which have been listed below. These side effects of Fivasa are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Fivasa has a Moderate effect for pregnant women and Mild effect on lactating mothers. Further, the section on Fivasa related warnings talks about Fivasa's effects on the liver, heart and kidney.
The section on Fivasa contraindications lists all such conditions.
Drug reaction of Fivasa with other medicines has been reported. Refer to the list below for further details.
In addition to these precautions, you may also note that Fivasa is safe while driving, and is is addictive in nature.
Fivasa is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Fivasa safe for pregnant women?
Fivasa may have some side effects during pregnancy. Pregnant women should discontinue the use of Fivasa, and talk to their doctor, if they notice any discomfort.
Is the use of Fivasa safe during breastfeeding?
Side effects of Fivasa for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Fivasa on the Kidneys?
Fivasa is completely safe for kidneys.
What is the effect of Fivasa on the Liver?
There may be an adverse effect on the liver after taking Fivasa. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Fivasa on the Heart?
The heart can be affected by Fivasa. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Fivasa should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Fivasa unless your doctor advises you to do so -
Is this Fivasa habit forming or addictive?
No, you will not get addicted to Fivasa.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Fivasa since it will not make you feel sleepy.
Is it safe?
Fivasa should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Fivasa in mental disorders is not effective.
Interaction between Food and Fivasa
There isn't any research available on the side effects of taking Fivasa with food.
Interaction between Alcohol and Fivasa
It is difficult to say anything about the effect of Fivasa and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359